New Pan-Tumor Approval For Targeted Drug Enhertu Industry Leader Ashley Gaines Says Many More Oncologists & Patients Need To Be Aware of HER2 Testing

IHC testing identifies HER2 proteins in a variety of cancers to help identify personalized treatments with drugs like Enhertu.